4 cough syrups by Indian pharma firm linked to deaths of 66 children in Gambia: WHO
Don't Miss
- India expels Pakistani official at Pak mission: The External Affairs Ministry said the official has been given 24 hours to leave India
- Pak president prime minister pay tributes to 11 soldiers killed 78 others injured in Indian attacks
- Trump trade war faces legal challenge as businesses states argue his tariffs exceeded his power
WHO has said that four cough syrups by India's Maiden Pharmaceuticals are potentially linked to deaths in Gambia.
|
| WHO director-general Tedros Adhanom Ghebreyesus has recommended all countries detect and remove these products from circulation. (Photo: AP) |
Sneha Mordani , IndiaToday, New Delhi, October 5, 2022: The World Health Organization (WHO) has issued a medical product alert for four contaminated medicines identified in Gambia that have been potentially linked with acute kidney injuries and 66 deaths among children.
According to WHO, the four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited in India. The global health body said it is conducting further investigation with the company and regulatory authorities in India.
WHO chief Dr Tedros Adhanom Ghebreyesus, at a media briefing, said, "The loss of these young lives is beyond heartbreaking for their families. The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. WHO is conducting further investigation with the company and regulatory authorities in India."
While the contaminated products have so far only been detected in Gambia, they may have been distributed to other countries. The WHO has recommended all countries detect and remove these products from circulation to prevent further harm to patients.
0 Response to " 4 cough syrups by Indian pharma firm linked to deaths of 66 children in Gambia: WHO"
Post a Comment
Disclaimer Note:
The views expressed in the articles published here are solely those of the author and do not necessarily reflect the official policy, position, or perspective of Kalimpong News or KalimNews. Kalimpong News and KalimNews disclaim all liability for the published or posted articles, news, and information and assume no responsibility for the accuracy or validity of the content.
Kalimpong News is a non-profit online news platform managed by KalimNews and operated under the Kalimpong Press Club.
Comment Policy:
We encourage respectful and constructive discussions. Please ensure decency while commenting and register with your email ID to participate.
Note: only a member of this blog may post a comment.